Predict your next investment

Venture Capital
triventures.net

See what CB Insights has to offer

Investments

40

Portfolio Exits

3

Funds

4

Partners & Customers

1

About TriVentures

Triventures is a venture capital fund focused on investing in medical device and digital health technologies from seed stage to industry leaders. The firm has over $100 million under management dedicated to ventures primarily in Israel and the U.S.

TriVentures Headquarter Location

11 Hasadnaot St. Sea View Building #B, 5th Floor

Herzliya, 4673300,

Israel

+972-9-779-3800

Predict your next investment

The CB Insights tech market intelligence platform analyzes millions of data points on venture capital, startups, patents , partnerships and news mentions to help you see tomorrow's opportunities, today.

Latest TriVentures News

Brightside Health Raises $50M in Series B Funding

Mar 29, 2022

Brightside Health , a San Francisco, CA-based telemedicine platform that offers fast access to personalized treatment, expert providers, and ongoing support for a range of mental health concerns, raised $50m in Series B funding. The round, which brought total funding to date to $75m, was led by ACME Capital and Mousse Partners, with participation from existing investors Bullpen Capital, Triventures, and Trousdale Ventures. Led by Brad Kittredge, founder and CEO, Brightside Health is a telemedicine platform focused on developing and delivering a new standard of mental health care. By pairing empathy and expertise with innovative technology, the company provides a personalized treatment experience for every member through video visits, unlimited messaging, ongoing support, and medication delivery. Its care model encompasses precision-psychiatry, a clinically-proven approach to therapy, and continuous care monitoring from a network of providers. Brightside Health treats the full spectrum of symptom severity, including people with complex conditions, and offers timely appointments from home, available in as little as 24 hours. With convenient access to treatment through video visits, unlimited messaging, ongoing support, and medication delivery, Brightside Health helps people feel better faster, and stay that way longer. The platform adheres to evidence-based approaches, guided by a world-class network of psychiatric providers and licensed therapists who utilize innovative support tools and follow structured, clinically-proven protocols to deliver effective care at scale. Members track progress through online check-ins that are also monitored by providers, ensuring the efficacy of personalized treatment plans and enabling rapid intervention should a need arise. FinSMEs

TriVentures Investments

40 Investments

TriVentures has made 40 investments. Their latest investment was in Future Family as part of their Series B on April 4, 2022.

CBI Logo

TriVentures Investments Activity

investments chart

Date

Round

Company

Amount

New?

Co-Investors

Sources

4/5/2022

Series B

Future Family

$25M

Yes

2

12/13/2021

Seed VC - II

Lynx.MD

$12M

No

2

12/8/2021

Series B

Brightside

$50M

Yes

2

6/9/2021

Seed VC

Subscribe to see more

$99M

Subscribe to see more

10

6/7/2021

Series B

Subscribe to see more

$99M

Subscribe to see more

10

Date

4/5/2022

12/13/2021

12/8/2021

6/9/2021

6/7/2021

Round

Series B

Seed VC - II

Series B

Seed VC

Series B

Company

Future Family

Lynx.MD

Brightside

Subscribe to see more

Subscribe to see more

Amount

$25M

$12M

$50M

$99M

$99M

New?

Yes

No

Yes

Subscribe to see more

Subscribe to see more

Co-Investors

Sources

2

2

2

10

10

TriVentures Portfolio Exits

3 Portfolio Exits

TriVentures has 3 portfolio exits. Their latest portfolio exit was Cardiva Medical on January 20, 2021.

Date

Exit

Companies

Valuation
Valuations are submitted by companies, mined from state filings or news, provided by VentureSource, or based on a comparables valuation model.

Acquirer

Sources

1/20/2021

Acquired

$99M

5

3/14/2019

Acquired

Subscribe to see more

$99M

Subscribe to see more

10

9/24/2018

Acquired

Subscribe to see more

$99M

Subscribe to see more

10

Date

1/20/2021

3/14/2019

9/24/2018

Exit

Acquired

Acquired

Acquired

Companies

Subscribe to see more

Subscribe to see more

Valuation

$99M

$99M

$99M

Acquirer

Subscribe to see more

Subscribe to see more

Sources

5

10

10

TriVentures Fund History

4 Fund Histories

TriVentures has 4 funds, including Triventures ARC.

Closing Date

Fund

Fund Type

Status

Amount

Sources

9/18/2019

Triventures ARC

$40M

2

5/18/2015

TriVentures III

Subscribe to see more

Subscribe to see more

$99M

10

12/31/2009

TriVentures II Fund LP

Subscribe to see more

Subscribe to see more

$99M

10

Triventures ARC Fund

Subscribe to see more

Subscribe to see more

10

Closing Date

9/18/2019

5/18/2015

12/31/2009

Fund

Triventures ARC

TriVentures III

TriVentures II Fund LP

Triventures ARC Fund

Fund Type

Subscribe to see more

Subscribe to see more

Subscribe to see more

Status

Subscribe to see more

Subscribe to see more

Subscribe to see more

Amount

$40M

$99M

$99M

Sources

2

10

10

10

TriVentures Partners & Customers

1 Partners and customers

TriVentures has 1 strategic partners and customers. TriVentures recently partnered with Genoox on May 5, 2018.

Date

Type

Business Partner

Country

News Snippet

Sources

5/15/2018

Partner

United States

Triventures, Leading Healthcare Investor, Backs Genoox in $6 Million Funding Round

`` We are excited to kick off this partnership with Triventures , as we continue growing in the U.S. and addressing demand for streamlined , clinical genomics applications , '' said Amir Trabelsi , co-founder and CEO of Genoox .

4

Date

5/15/2018

Type

Partner

Business Partner

Country

United States

News Snippet

Triventures, Leading Healthcare Investor, Backs Genoox in $6 Million Funding Round

`` We are excited to kick off this partnership with Triventures , as we continue growing in the U.S. and addressing demand for streamlined , clinical genomics applications , '' said Amir Trabelsi , co-founder and CEO of Genoox .

Sources

4

TriVentures Team

5 Team Members

TriVentures has 5 team members, including current Founder, Managing Partner, Michal Geva.

Name

Work History

Title

Status

Peter J. Fitzgerald

Founder

Current

Michal Geva

Founder, Managing Partner

Current

Martin B Leon

Founder

Current

Dani Goldsher

LR Group, and Deloitte

Chief Financial Officer

Current

Netalie Nadivi

Philips, Viola Networks, and KenTech Ventures

General Partner

Current

Name

Peter J. Fitzgerald

Michal Geva

Martin B Leon

Dani Goldsher

Netalie Nadivi

Work History

LR Group, and Deloitte

Philips, Viola Networks, and KenTech Ventures

Title

Founder

Founder, Managing Partner

Founder

Chief Financial Officer

General Partner

Status

Current

Current

Current

Current

Current

Discover the right solution for your team

The CB Insights tech market intelligence platform analyzes millions of data points on vendors, products, partnerships, and patents to help your team find their next technology solution.

Request a demo

CBI websites generally use certain cookies to enable better interactions with our sites and services. Use of these cookies, which may be stored on your device, permits us to improve and customize your experience. You can read more about your cookie choices at our privacy policy here. By continuing to use this site you are consenting to these choices.